Replies to post #360323 on Anavex Life Sciences Corp (AVXL)

[frrol]

These events are helpful. The company will solicit questions, so folks should consider what to ask. Mine:

- What stratifications, if any, do we currently plan to apply to the AD results
- Why were stock incentives only for AD trial completion
- Did we apply for Rett BTD
- Further background on the 2-73 AD IP risk disclosures

Only the first one has good chance of response, but that's OK.

[nidan7500]

Sponsoring and R&D event like this is potentially a great idea. BUT...you better have something to say.

IMO, such a planned activity would need to be something of consequence in a string of significant news..."Why should/would anyone even care???" .

There is a plan in here somewhere.

[ChrisMissing]

This r & d session of course will be big. I presume we will hear finally a deep dive into each indication and maybe we will get to hear the story about “ when we tell you why we did what we did you will then understand “. Or that question should be asked by someone. This to me is a transformational meeting. We should be getting something new for each indication. If not why do it. I’ll throw out a few potentials. PDD Ole data, maybe some Alzheimer’s ole data, new indication(s) update, start of p2 371 ftd, start of fragile X trial.

Feel free to add to this list. I think this is going to be huge.

[Jonjones325]

Hopefully by then he will have had the FDA meetings already.

That will provide much needed clarity.

[meds4life]

HOW can I, an AVXL shareholder, access the R&D event Tuesday ( tomorrow)???
Is there a time set?

thanks!